Clinical Trial Update: Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

View source ↗

Summary

An extension study is planned to evaluate long-term outcomes in pediatric patients who received treatment for retinopathy of prematurity in the VGFTe-ROP-1920 s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Retinopathy of Prematurity | Status: ACTIVE_NOT_RECRUITING